Stay updated on Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial
Sign up to get notified when there's something new on the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page.

Latest updates to the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page
- ChecktodayChange DetectedNo additions or deletions were detected; the Study Details page content remains focused on the trial's objectives, design, and locations.SummaryDifference0.3%

- Check7 days agoNo Change Detected
- Check29 days agoChange DetectedCore content updated with a government funding notice and a new software revision (v3.2.0), replacing the old v3.1.0; indicates a status update and new version release.SummaryDifference2%

- Check36 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' element was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check65 days agoChange DetectedThe web page has been updated to include a new facility name and location details, as well as recent publications related to dupilumab, while removing some previous location and topic information.SummaryDifference3%

Stay in the know with updates to Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page.